LRRK2-IN-1 (Standard)
LRRK2-IN-1 (Standard) is the analytical standard of LRRK2-IN-1 (HY-10875). This product is intended for research and analytical applications. LRRK2-IN-1 is a potent and selective LRRK2 inhibitor with IC50 of 6 nM and 13 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1234480-84-2
- 分子式: C31H38N8O3
- 分子量:570.69
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
化学情報
- 純度とドキュメンテーション
-
Help & FAQs
-
HY-10875
LRRK2-IN-1LRRK2 Inhibitor -
HY-13237
GSK2578215ALRRK2 Inhibitor -
HY-15796
GNE0877LRRK2 Inhibitor -
HY-12477
PF-06447475LRRK2 Inhibitor -
HY-18163
GNE-7915LRRK2 Inhibitor -
HY-100411
MLi-2LRRK2 Inhibitor -
HY-15800A
CZC-25146LRRK2 Inhibitor -
HY-13488
HG-10-102-01LRRK2 Inhibitor -
HY-12282
GNE-9605LRRK2 Inhibitor -
HY-B0792
CZC-54252LRRK2 Inhibitor -
HY-12990
Spautin-1Autophagy Inhibitor -
HY-16966
SBI-0206965ULK1/AMPK Inhibitor
Product Information
説明
アプリケーション
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
化学情報
-
CAS 番号 1234480-84-2
-
分子量 570.69
-
分子式 C31H38N8O3
-
SMILES
O=C(C1=CC(OC)=C(NC2=NC=C3C(N(C4=C(C(N3C)=O)C=CC=C4)C)=N2)C=C1)N5CCC(CC5)N6CCN(CC6)C
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Hermanson SB, et al. Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation.PLoS One. 2012;7(8):e43580. Epub 2012 Aug 28. [Content Brief]
[3]. Koshibu K, et al. Alternative to LRRK2-IN-1 for Pharmacological Studies of Parkinson's Disease. Pharmacology. 2015;96(5-6):240-7. [Content Brief]
[4]. Weygant N, et al. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1. Mol Cancer. 2014 May 6;13:103. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
LRRK2-IN-1 (Standard) 関連分類
HY-10875R 関連分類
Powered by Bioz